Paper Diagnostics Market
Paper Diagnostics Market By Product Type (Paper-based Lateral Flow Assays, Dipsticks, Paper Based Microfluidics), By End User (Hospitals & Clinics, Homecare Settings) & By Region - Global Insights to 2031
Analysis of Paper Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Paper Diagnostics
As per the latest industry analysis published by Fact.MR, global market for paper diagnostics is likely to be valued at US$ 7.2 Bn in 2021, and is slated to accelerate at a CAGR of 8.1% across the 2021-2031 forecast period, reflecting more than 2x increase. Paper-based lateral flow assays are projected to be most demanded, accumulating over 60% revenue until 2031.
Key Points Covered in Paper Diagnostics Industry Survey
- Market Estimates and Forecasts 2016-2031
- Key drivers and restraints shaping market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Paper Diagnostics Market and How to Navigate
- Recommendation and Key Winning Strategy
Sales Analysis of Paper Diagnostics 2016-2020 Vs Future Outlook 2021-2031
Historically, the global paper diagnostics market flourished at a robust rate of nearly 7% CAGR from 2016 to 2020. Rapid advancements in diagnostic approaches, including a shift towards low cost diagnosis, has been one of the key influencing factors impacting demand.
The COVID-19 pandemic further opened new avenues for the paper diagnostics industry expansion. With substantial limitations associated with mainstream diagnostic approaches (RT-PCR, ELISA and RT-LAMP), clinicians have been adopting paper diagnostics for understanding viral genome sequence and better understand its spread.
Soaring R&D investments and increasing government stimulus to the healthcare sector is expected to surge in the forecast period. The market worth is projected to reach US$ 15.7 Bn, following a CAGR of 8.1% during the 2021-2031 assessment period. Furthermore, growing cases of cancer and advanced healthcare infrastructure in North America will enhance paper diagnostics prospects in the upcoming decade.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Increasing Cases of Autoimmune Diseases Bolstering Growth
Rising cases of autoimmune diseases and cancers coupled with the growing awareness among solutions available for fast and prompt diagnosis have resulted in high demand for the early detection of these diseases. According to the recent report of National Institutes of Health (NIH) published in April, 2020, the prevalence of autoimmune diseases in the United States was 11.0% for 1988-1991 and it had been increasing steadily to reach at 11.5% during 1999-2004 and at 15.9% during 2011-2012.
Paper diagnostics provide promising solutions for early diagnosis of these diseases while emphasizing on the key aspects of the diagnosis procedure and outcomes such as affordability, sustainability, portability, disposability, and others. According to the National Health and Nutrition Examination Survey (NHANES) of NIH, the rate of auto-immune diseases is forecast to grow further in the United States in the coming years. The data indicates that demand for paper diagnostics will surge considerably in the coming years
Technological Advancements to Open More Opportunistic Doors?
Advances in printed electronics provide a fitting foundation for implementing augmented functionality, while maintaining the affordability and disposability of paper-based diagnostics. Introduction of the technologically advanced paper-based sensor, 3D wax printing methods have potential advantages over conventional technologies, correlated benefits such as user-friendliness disposable nature, and low cost of fabrication are the factors associating towards the growth of this industry.
Currently, paper-based sensors are focused on microfluidic delivery of solution to the detection site whereas more advanced designs involve complex 3-D geometries based on the same microfluidic principles. Moreover, increasing investments by government organizations in R&D pertaining to development of novel in vitro diagnostics tests and devices have been providing an upthrust to the market. For instance, European Diagnostic Manufacturers Association (EDMA), which focuses on development and overall growth of the in vitro diagnostic industry in Europe, invests approximately € 1 billion in R&D of in vitro diagnostics every year.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
How is Cancer Diagnostics Pushing Demand for Paper Diagnostics in the U.S?
The U.S is the epicentre for paper diagnostics in the world due to the burgeoning number of cancer cases and progressive healthcare infrastructure. According to the National Cancer Institute, the U.S. is likely to have 1,806,590 new cases of cancer in 2020 and nearly 606,520 people might succumb to the disease.
The demand for early and effective detection of cancer has therefore become a priority for the healthcare industry in North America. This in turn is boosting the demand for paper diagnostics in the region. According to Fact.MR, the country is expected to surge at over 8% CAGR.
The U.S has some of the world’s R&D facilities allowing it to offer some of the most cutting-edge items to the clients. For instance, a group of engineers from the Massachusetts Institute of Technology (MIT) have developed an inexpensive paper-based test which could improve cancer diagnosis rates based on urine samples by analysing biomarkers.
How is the Prevention of Infectious Diseases Outbreaks Driving Adoption in China?
According to fact.MR, China is likely to generate high prospects for the paper diagnostics industry, registering a CAGR of 6.6% during the forecast period.
High burden of chronic and infectious diseases, including diabetes, cancer, and COVID-19, is slated to significantly propel growth, as these chronic disorders can be diagnosed and monitored using paper diagnostic products.
According to the World Health Organization (WHO), 102,762 COVID-19 cases were recorded as of March 2021, with 4,851 deaths in China. The increasing burden of the COVID-19 pandemic will lead to a high requirement of tests, which will boost the paper diagnostics market in the country.
Category-wise Insights
Why Lateral Flow Assays are experiencing an Incline in the Industry?
Currently, lateral flow assays are the leading segment in terms of product type in the global market for paper diagnostics. This segment will likely account for over 60% revenue until 2031. Growth can be attributed to extensive usage rate as pregnancy tests.
Besides, mounting incidence of infectious diseases such as HIV, TB, and pneumonia is assessed to spur the growth of the segment during the forecast period. Lateral flow assay (LFA) has made a paradigm shift in the in vitro diagnosis field due to its rapid turnaround time, ease of operation and exceptional affordability. Currently used LFAs predominantly use antibodies.
How did COVID-19 Spur Paper Diagnostics across Hospitals & Clinics?
In terms of end-user, hospitals and clinics are the foremost utilizers of paper diagnostics. With the increase in awareness among doctors, other healthcare staff, and patients, the demand for paper diagnostics solutions is rising. Fact.MR expects the segment to experience a CAGR of 7% until 2031.
During the height of the coronavirus pandemic, documented limitations associated with rapid diagnostic approaches such as RT-PCR (real-time PCR), RT-LAMP and ELISA prompted high reliance on paper-based diagnostics, capable of testing viral genome sequence to reflect information on the spread and distribution of the pathogen, especially in wastewater.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, enhanced R&D investments, technological advancements and mergers.
- The Wyss Institute has developed paper-based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient-care. This new type pf platform may also provide patients and consumers with simple-to-use texts for a variety of other health problems.
- In Sept 2017, U.S. ARKRAY, Inc. (ARKRAY) launched the ADAMS™ A1c HA-8180V System for haemoglobin A1c testing. The system obtained FDA 510(k) clearance as an aid in the monitoring and diagnosis of individuals with diabetes. This fully automated analyser utilizes gold standard HPLC technology.
Report Scope
|
Attribute |
Details |
|
Market size value in 2020 |
USD 7.2 Billion |
|
Market forecast value in 2031 |
USD 15.7 Billion |
|
Growth Rate |
CAGR of 8.1% (2021-2031) |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments Covered
-
Product
- Paper-based Lateral Flow Assays
- Paper-based Dipsticks
- Paper-based Micro Fluidics
-
End User
- Paper Diagnostics for Hospitals & Clinics
- Paper Diagnostics for Home Care Settings
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Paper Diagnostics Market 3.2. Product Innovation / Development Trends 4. Market Context 4.1. Key Product Features and their USPs 4.2. Product Adoption / Usage Analysis 4.3. Disease Epidemiology 4.4. Key Promotional Strategies, By Manufacturers 4.5. Regulations, By Region 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Rise in Healthcare Expenditure 5.1.2. Increasing R&D Expenditure 5.1.3. Income Per Capita Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Prevalence of Diseases such as Cancer and Autoimmune Diseases 5.2.2. Increasing Demand for Novel and Rapid Diagnostics Techniques 5.2.3. Growing Levels of Pollution in Environments Resulting in Greater Concerns Regarding Detection of Pollutants 5.2.4. Increasing Adaption of the Point of Care Diabetes and Pregnancy Test Kits 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 5.4. Market Entry Strategy 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue by Product 6.4.2. Revenue by End User 6.4.3. Revenue by Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected recovery Quarter 6.8. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Global Paper Diagnostics Market - Pricing Analysis 7.1. Country Pricing Analysis by Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Latin America and Middle East Average Pricing Analysis Benchmark 8. Global Paper Diagnostics Market Value Analysis 2016 – 2020 and Forecast, 2021 – 2031 8.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020 8.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis by Product, 2016 – 2020 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, 2021 – 2031 9.3.1. Lateral Flow Assays 9.3.2. Dipsticks 9.3.3. Paper Based Microfluidics 9.4. Market Attractiveness Analysis by Product 10. Global Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis by End User, 2016 – 2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2021 – 2031 10.3.1. Hospitals & Clinics 10.3.2. Homecare Settings 10.4. Market Attractiveness Analysis, by End User 11. Global Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis by Region, 2016 – 2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis by Region 11.5. SWOT Analysis by Region 12. North America Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 13. Latin America Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 14. Europe Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. Rest of Europe 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. South Asia Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. East Asia Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.1.4. Rest of East Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. Oceania Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2021 - 2031 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021 - 2031 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. South Africa 18.3.1.3. Rest of Middle East and Africa 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 19. Key and Emerging Countries Paper Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. U.S. Paper Diagnostics Market Analysis 19.2.1. By Product 19.2.2. By End User 19.3. Canada Paper Diagnostics Market Analysis 19.3.1. By Product 19.3.2. By End User 19.4. Mexico Paper Diagnostics Market Analysis 19.4.1. By Product 19.4.2. By End User 19.5. Brazil Paper Diagnostics Market Analysis 19.5.1. By Product 19.5.2. By End User 19.6. U.K. Paper Diagnostics Market Analysis 19.6.1. By Product 19.6.2. By End User 19.7. Germany Paper Diagnostics Market Analysis 19.7.1. By Product 19.7.2. By End User 19.8. France Paper Diagnostics Market Analysis 19.8.1. By Product 19.8.2. By End User 19.9. Italy Paper Diagnostics Market Analysis 19.9.1. By Product 19.9.2. By End User 19.10. Spain Paper Diagnostics Market Analysis 19.10.1. By Product 19.10.2. By End User 19.11. BENELUX Paper Diagnostics Market Analysis 19.11.1. By Product 19.11.2. By End User 19.12. Russia Paper Diagnostics Market Analysis 19.12.1. By Product 19.12.2. By End User 19.13. China Paper Diagnostics Market Analysis 19.13.1. By Product 19.13.2. By End User 19.14. Japan Paper Diagnostics Market Analysis 19.14.1. By Product 19.14.2. By End User 19.15. South Korea Paper Diagnostics Market Analysis 19.15.1. By Product 19.15.2. By End User 19.16. India Paper Diagnostics Market Analysis 19.16.1. By Product 19.16.2. By End User 19.17. ASEAN Paper Diagnostics Market Analysis 19.17.1. By Product 19.17.2. By End User 19.18. Australia Paper Diagnostics Market Analysis 19.18.1. By Product 19.18.2. By End User 19.19. New Zealand Paper Diagnostics Market Analysis 19.19.1. By Product 19.19.2. By End User 19.20. GCC Countries Paper Diagnostics Market Analysis 19.20.1. By Product 19.20.2. By End User 19.21. Turkey Paper Diagnostics Market Analysis 19.21.1. By Product 19.21.2. By End User 19.22. South Africa Paper Diagnostics Market Analysis 19.22.1. By Product 19.22.2. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional Foot Print of Players 20.4.2. Product Foot Print by Players 20.4.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Pricing Analysis by Competition 21.3. Competition Benchmarking 21.4. Competition Deep Dive 21.4.1. Abcam PLC 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.1.4. Sales Footprint 21.4.1.5. Strategy Overview 21.4.1.5.1. Marketing Strategy 21.4.1.5.2. Product Strategy 21.4.1.5.3. Channel Strategy 21.4.2. Acon Laboratories 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.2.4. Sales Footprint 21.4.2.5. Strategy Overview 21.4.2.5.1. Marketing Strategy 21.4.2.5.2. Product Strategy 21.4.2.5.3. Channel Strategy 21.4.3. Bio-Rad Laboratories Inc. 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.3.4. Sales Footprint 21.4.3.5. Strategy Overview 21.4.3.5.1. Marketing Strategy 21.4.3.5.2. Product Strategy 21.4.3.5.3. Channel Strategy 21.4.4. Siemens Healthineers 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.4.4. Sales Footprint 21.4.4.5. Strategy Overview 21.4.4.5.1. Marketing Strategy 21.4.4.5.2. Product Strategy 21.4.4.5.3. Channel Strategy 21.4.5. Chembio Diagnostic Systems Inc. 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.5.4. Sales Footprint 21.4.5.5. Strategy Overview 21.4.5.5.1. Marketing Strategy 21.4.5.5.2. Product Strategy 21.4.5.5.3. Channel Strategy 21.4.6. Arkray Inc. 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.6.4. Sales Footprint 21.4.6.5. Strategy Overview 21.4.6.5.1. Marketing Strategy 21.4.6.5.2. Product Strategy 21.4.6.5.3. Channel Strategy 21.4.7. Cytodiagnostics Inc. 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Profitability by Market Segments (Brand/Distribution Channel/Region) 21.4.7.4. Sales Footprint 21.4.7.5. Strategy Overview 21.4.7.5.1. Marketing Strategy 21.4.7.5.2. Product Strategy 21.4.7.5.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 02: Global Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 03: Global Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 04: North America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 05: North America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 06: North America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 07: Latin America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 08: Latin America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 09: Latin America Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 10: Europe Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 11: Europe Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 12: Europe Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 13: South Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 14: South Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 15: South Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 16: East Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 17: East Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 18: East Asia Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 19: Oceania Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 20: Oceania Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 21: Oceania Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 22: MEA Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Country
Table 23: MEA Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 24: MEA Paper Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 02: Global Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 03: Global Paper Diagnostics Market Absolute $ Opportunity, 2021 – 2031
Figure 04: Paper Diagnostics Pricing Analysis (US$) for Per Unit, By Region, 2020
Figure 05: Global Paper Diagnostics Market Share Analysis (%), By Product, 2021-2031
Figure 06: Global Paper Diagnostics Market Y-o-Y Analysis (%), By Product, 2021-2031
Figure 07: Global Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 08: Global Paper Diagnostics Market Share Analysis (%), By End User, 2021-2031
Figure 09: Global Paper Diagnostics Market Y-o-Y Analysis (%), By End User, 2021-2031
Figure 10: Global Paper Diagnostics Market Attractiveness Analysis, By End User, 2021-2031
Figure 11: Global Paper Diagnostics Market Share Analysis (%), By Region, 2021-2031
Figure 12: Global Paper Diagnostics Market Y-o-Y Analysis (%), By Region, 2021-2031
Figure 13: Global Paper Diagnostics Market Attractiveness Analysis, By Region, 2021-2031
Figure 14: North America Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 15: North America Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 16: North America Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 17: North America Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 18: North America Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 19: North America Paper Diagnostics Market Attractiveness Analysis, by Product, 2021-2031
Figure 20: North America Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 21: North America Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 22: Latin America Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 23: Latin America Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 24: Latin America Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 25: Latin America Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 26: Latin America Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 27: Latin America Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 28: Latin America Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 29: Latin America Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 30: Europe Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 31: Europe Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 32: Europe Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 33: Europe Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 34: Europe Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 35: Europe Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 36: Europe Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 37: Europe Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 38: South Asia Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 39: South Asia Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 40: South Asia Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 41: South Asia Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 42: South Asia Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 43: South Asia Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 44: South Asia Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 45: South Asia Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 46: East Asia Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 47: East Asia Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 48: East Asia Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 49: East Asia Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 50: East Asia Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 51: East Asia Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 52: East Asia Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 53: East Asia Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 54: Oceania Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 55: Oceania Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 56: Oceania Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 57: Oceania Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 58: Oceania Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 59: Oceania Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 60: Oceania Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 61: Oceania Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 62: MEA Paper Diagnostics Market Value Share, By Product, 2021 (E)
Figure 63: MEA Paper Diagnostics Market Value Share, By End User, 2021 (E)
Figure 64: MEA Paper Diagnostics Market Value Share, By Country, 2021 (E)
Figure 65: MEA Paper Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 66: MEA Paper Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 67: MEA Paper Diagnostics Market Attractiveness Analysis, By Product, 2021-2031
Figure 68: MEA Paper Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 69: MEA Paper Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 70: U. S. Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 71: U. S. Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 72: Global Vs. U.S Growth Comparison
Figure 73: Canada Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 74: Canada Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 75: Global Vs. Canada Growth Comparison
Figure 76: Germany Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 77: Germany Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 78: Global Vs. Germany Growth Comparison
Figure 79: U. K. Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 80: U. K. Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 81: Global Vs. U. K. Growth Comparison
Figure 82: France Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 83: France Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 84: Global Vs. France Growth Comparison
Figure 85: Italy Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 86: Italy Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 87: Global Vs. Italy Growth Comparison
Figure 88: Spain Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 89: Spain Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 90: Global Vs. Spain Growth Comparison
Figure 91: Russia Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 92: Russia Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 93: Global Vs. Russia Growth Comparison
Figure 94: Japan Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 95: Japan Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 96: Global Vs. Japan Growth Comparison
Figure 97: China Paper Diagnostics Market Value Share, By Product, 2021 &2031
Figure 98: China Paper Diagnostics Market Value Share, By End User, 2021 &2031
Figure 99: Global Vs. China Growth Comparison
Figure 100: South Korea Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 101: South Korea Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 102: Global Vs South Korea Growth Comparison
Figure 103: India Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 104: India Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 105: Global Vs India Growth Comparison
Figure 106: Thailand Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 107: Thailand Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 108: Global Vs Thailand Growth Comparison
Figure 109: Malaysia Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 110: Malaysia Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 111: Global Vs Malaysia Growth Comparison
Figure 112: Indonesia Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 113: Indonesia Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 114: Global Vs Indonesia Growth Comparison
Figure 115: Australia Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 116: Australia Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 117: Global Vs Australia Growth Comparison
Figure 118: New Zealand Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 119: New Zealand Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 120: Global Vs New Zealand Growth Comparison
Figure 121: GCC Countries Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 122: GCC Countries Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 123: Global Vs GCC Countries Growth Comparison
Figure 124: Turkey Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 125: Turkey Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 126: Global Vs Turkey Growth Comparison
Figure 127: South Africa Paper Diagnostics Market Share Analysis (%), By Product, 2021 &2031
Figure 128: South Africa Paper Diagnostics Market Share Analysis (%), By End User, 2021 &2031
Figure 129: Global Vs South Africa Growth Comparison
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the paper diagnostics market worth?
As of 2021, paper diagnostics demand is estimated to reach nearly US$ 7.5 Bn
What was the last 5 years CAGR for the paper diagnostics industry?
From 2016 to 2020, paper diagnostics demand surged at a CAGR of 7%, as per Fact.MR
What are the future growth projections for paper diagnostics?
From 2021 to 2031, the market for paper diagnostics is projected to surge at a CAGR of 8.1%.
What is the anticipated valuation for the paper diagnostics industry by 2031?
According to Fact.MR, paper diagnostics value is likely to reach US$ 15.7 Bn by 2031
What factors drive the demand for paper diagnostics?
Growing incidences of autoimmune disorders as well as the foray to discover inexpensive alternatives are spurring paper diagnostics demand
What is the growth outlook for the Chinese paper diagnostics industry?
As per Fact.MR, demand for paper diagnostics in China is scheduled to expand at a CAGR of 6.6%
How opportunistic are prospects across the U.S?
The U.S is slated to experience a growth rate of over 8% across the 2021-2031 forecast period
Which key manufacturers operate in the paper diagnostics domain?
ARKRAY Inc., Acon Laboratories, Inc., Abbott, Bio-Rad Laboratories, Abcam Plc, Chembio Diagnostic Systems, Inc., FFEI, Navigene, Creative Diagnostics, Siemens Healthcare Gmbh., are some players operating in the paper diagnostics domain
Which is the fastest growing paper diagnostics product type?
Lateral Flow Assays are the most preferred, capturing 60% of the global revenue until 2031
Paper Diagnostics Market